Document is current
Any future updates will be listed below
-
Authors
Ludvigsson, Jonas F.
Berglind, Daniel
Sundquist, Kristina
Sundström, Johan
Tynelius, Per
Neovius, Martin https://orcid.org/0000-0003-2300-3055
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 7 October 2021
Accepted: 1 June 2022
First Online: 9 July 2022
Declarations
:
: Dr Ludvigsson coordinates a study on behalf of the Swedish IBD quality register (SWIBREG). That study has received funding from the Janssen corporation. Dr Sundström reports stock ownership in companies providing services to Itrim, Amgen, Janssen, Novo Nordisk, Eli Lilly, Boehringer, Bayer, Pfizer and AstraZeneca, outside the submitted work. Dr Neovius reports advisory board participation for Ethicon, Johnson & Johnson and Itrim, and consultancy for the Armed Forces outside the submitted work.
